Caidya was honored at the CRO Leadership Awards held in Boston, MA at the end of June for their win in the Overall Capabilities category. The award is a recognition of Caidya’s outstanding global capabilities and the tireless work that the team does daily to fulfill our vision to ensure potential therapies have the best opportunity to reach patients in need.
Sanofi, Meningitis Research Foundation, and the Confederation of Meningitis Organisations ignite a global awareness initiative against meningitis with launch of The Meningitis Flag
Hiring and retaining talented entry-level professionals is crucial for the success of any life science company. These individuals can bring fresh perspectives and innovative ideas to your organisation. Investing in early talent is also essential for your succession planning, and means you’ll be nurturing top talent from the very start of their journeys. However, in a competitive job market, it can be challenging to attract and retain these individuals.
NEW BRUNSWICK, N.J., August 23, 2023 – Johnson & Johnson (NYSE: JNJ) today announced the final results of its previously announced offer to its shareholders to exchange their shares of Johnson & Johnson common stock for shares of Kenvue Inc. (NYSE: KVUE) (“Kenvue”) common stock owned by Johnson & Johnson. The exchange offer expired at 12:00 midnight, New York City time, at the end of the day on August 18, 2023.
Fraudulent candidates are individuals who intentionally deceive employers by misrepresenting their qualifications, skills, or experience during the job application process. In the life science industry, these candidates pose a significant threat to employers.
23 August 2023: Kadans Science Partner (“Kadans”) is set to welcome AviadoBio to its recently completed wet lab innovation and flexible workspace centre at 20 Water Street in Canary Wharf.
As employers in the life science industry, it’s essential to offer attractive employee benefits that can help attract and retain top talent. Whilst providing competitive salaries is undoubtedly important, there are other things you must do in order to stand out against your competitors, especially if you don’t have the budget to compete with the compensation packages being offered by industry leaders.
INDIANAPOLIS, Aug. 14, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Sigilon Therapeutics, Inc. (NASDAQ: SGTX). The acquisition allows Lilly to continue researching and developing encapsulated cell therapies, including SIG-002, for the treatment of type 1 diabetes.
INDIANAPOLIS, Aug. 14, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Versanis Bio. The acquisition expands Lilly's portfolio to include Versanis' lead asset, bimagrumab, which is currently being assessed in a Phase 2b study alone and in combination with semaglutide in adults living with overweight or obesity.
The two organizations are joining forces to develop pioneering AI-based solutions for efficient chemical synthesis planning to accelerate the development of novel pharmaceuticals.
